Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate vs Placebo in Exudative AMD
NCT00058994Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2003
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anecortave in exudative age-related macular degeneration, sponsored by Alcon Inc.. Started Mar 2003; status: completed.
02
Drugs
anecortave
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00058994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058994.